(Q34375161)

1 August 2017

title

Optimum bile acid treatment for rapid gall stone dissolution (English)

1 reference

1 August 2017

Jazrawi RP

1

1 reference

1 August 2017

Pigozzi MG

2

1 reference

1 August 2017

Galatola G

3

1 reference

1 August 2017

Lanzini A

4

1 reference

1 August 2017

Northfield TC

5

1 reference

1 August 2017

language of work or name

English

0 references

publication date

1 March 1992

1 reference

1 August 2017

1 reference

1 August 2017

volume

33

1 reference

1 August 2017

issue

3

1 reference

1 August 2017

page(s)

381-386

1 reference

Chenodiol (chenodeoxycholic acid) for dissolution of gallstones: the National Cooperative Gallstone Study. A controlled trial of efficacy and safety

1 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1373833

Chenodeoxycholic acid: a review of its pharmacological properties and therapeutic use.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1373833

Factors affecting gall-stone dissolution rate during chenic acid therapy

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1373833

Calcification of radiolucent gall stone during treatment with ursodeoxycholic acid.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1373833

Pilot study of combination treatment for gall stones with medium dose chenodeoxycholic acid and a terpene preparation.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1373833

Ursodeoxycholic acid: a review of its pharmacological properties and therapeutic efficacy

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1373833

Comparative efficacy and side effects of ursodeoxycholic and chenodeoxycholic acids in dissolving gallstones. A double-blind controlled study

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1373833

Dissolution of Cholesterol Gallstones by Chenodeoxycholic Acid

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1373833

Gallstone dissolution in man using chenodeoxycholic acid.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1373833

Chenodeoxycholic acid treatment of gallstones. A follow-up report and analysis of factors influencing response to therapy

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1373833

Causes and consequences of placental growth retardation

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1373833

Optimal timing of doses of chenic acid in patients with gall stones

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1373833

In vivo dissolving of gall-stones: the effect of chenodeoxycholic acid. (author's transl)

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1373833

Ursodeoxycholic acid treatment of gallstones. Dose-response study and possible mechanism of action

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1373833

Dissolution of cholesterol gallstones by ursodeoxycholic acid

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1373833

Ursodeoxycholic acid vs. chenodeoxycholic acid as cholesterol gallstone-dissolving agents: a comparative randomized study.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1373833

Treatment of radiolucent gallstones with CDCA or UDCA. A multicenter trial.

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1373833

Drug and treatment efficacy of chenodeoxycholic acid in 97 patients with cholelithiasis and increased surgical risk.

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1373833

Gallstone dissolution rate during chenic acid therapy. Effect of bedtime administration plus low cholesterol diet

27 October 2018

1 reference

12 December 2020

Clinical studies on cheno- and ursodeoxycholic acid treatment for gallstone dissolution

1 reference

12 December 2020

Analysis of response to ursodeoxycholic acid for gallstone dissolution

1 reference

12 December 2020

Effectiveness of ursodeoxycholic acid in gallstone therapy

1 reference

12 December 2020

The medical treatment of cholesterol gallstones: experience with chenodeoxycholic acid

1 reference

12 December 2020

Efficacy and safety of a combination of chenodeoxycholic acid and ursodeoxycholic acid for gallstone dissolution: a comparison with ursodeoxycholic acid alone

1 reference

12 December 2020

[Retrospective studies on gallstone disappearance (author's transl)]

1 reference

12 December 2020

Additional Chenodiol Therapy After Partial Dissolution of Gallstones with Two Years of Treatment

1 reference

12 December 2020

Comparison of a monitored dose with a standard dose of chenodeoxycholic acid for gallstone dissolution

1 reference

12 December 2020

Ursodeoxycholic acid for the dissolution of radiolucent gall bladder stones

1 reference

12 December 2020

Franco-Belgian cooperative study of ursodeoxycholic acid in the medical dissolution of gallstones: a double-blind, randomized, dose-response study, and comparison with chenodeoxycholic acid

1 reference

12 December 2020

Gallstone dissolution and the cholesterol--bile acid--lipoprotein axis. Propitious effects of ursodeoxycholic acid

1 reference

12 December 2020

Efficacy and indications of ursodeoxycholic acid treatment for dissolving gallstones. A multicenter double-blind trial. Tokyo Cooperative Gallstone Study Group

1 reference

12 December 2020

Outcome of chenodeoxycholic acid (CDCA) treatment in 125 patients with radiolucent gallstones. Factors influencing efficacy, withdrawal, symptoms and side effects and post-dissolution recurrence

1 reference

12 December 2020

Ursodeoxycholic acid in the treatment of cholesterol cholelithiasis. part I

1 reference

12 December 2020

Effect of high and low doses of ursodeoxycholic acid on gallstone dissolution in humans

1 reference

12 December 2020

Effects of biliary bile acid composition on biliary cholesterol saturation in gallstone patients treated with chenodeoxycholic acid and/or ursodeoxycholic acid

1 reference

12 December 2020

Ursodeoxycholic acid: a safe and effective agent for dissolving cholesterol gallstones

1 reference

12 December 2020

Identifiers

DOI

10.1136/GUT.33.3.381

1 reference

1 August 2017

1 reference

1 August 2017

1 reference